InsiderTrades

Form 4 for REPL Replimune Group, Inc.

Accepted 2026-06-03 20:30:04 ET · period of report 2026-06-01 · accession 0001104659-26-070256 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
T 2026-06-03 20:30 2026-06-01 REPL Sarchi Christopher Chief Commercial Off S - Sale $9.24 -12.0K 181.0K -6% -$110.9K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-06-01 S D 12,000 $9.24 180,962 D — — (F1) The sales reported on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on December 15, 2025, that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. (F2) The price reported reflects a weighted average price of the Shares. The Shares were sold in multiple transactions at prices ranging from $9.15 to $9.62 per Share. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the Securities Exchange Commission staff, upon request, information regarding the number of Shares sold at each price within the range.